Enzon Pharmaceuticals Inc

0% 0 pts during the current or most recent trading day
Spread Bet: DFB Ways to deal
Delayed Prices
or Sign up to see live prices
Sell 108.0
Buy 108.0
Product details
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
Today
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
 
Copyright 2015 Thomson Reuters Ltd.  Click for restrictions
Open High Low Change % Change
109 0 0

BRIEF: For the fiscal year ended 31 December 2014, Enzon Pharmaceuticals Inc revenues decreased 10% to $31.2M. Net income increased 59% to $28.8M. Revenues reflect Miscellaneous income decrease of 79% to $135K. Net income reflects General and administrative decrease of 73% to $2.4M (expense), Restructuring charges decrease from $4.8M (expense) to $0K, Research and development decrease from $2.7M (expense) to $0K.

2015-03-25T09:44:37+00:00

Total Equity

Balance Sheet

Cash from Operating Activities

Cash Flow

Our shares technology

Start trading with IG

Try the new standard in stockbroking

Open an IG stocks and shares ISA
before 5 April to make the most of
your 2014/15 allowance

Learn more

  • 100% of IG client accounts with open positions in this market expect the price to rise
  • 0% of IG client accounts with open positions in this market expect the price to fall
  • < 10 IG client accounts have open positions in this market
  1. Last hour
    No trades
  2. Today
    No trades
  3. This week
    No trades
  4. This month
    No trades

Related

  • Global
  • United States
Market cap
Xenetic Biosciences Inc USD 30.08M
Biota Pharmaceuticals Inc USD 80.73M
Pain Therapeutics Inc USD 86.48M
Cardiome Pharma Corp USD 154.81M
Peregrine Pharmaceuticals Inc USD 254.25M
Vivus Inc USD 255.55M
Organovo Holdings Inc USD 284.82M

Events

  • Past
  • Future
  • JAN
    08
    Enzon Pharmaceuticals Inc Dividend For ENZN
    2 months ago